Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
0CUtf7V3AzbzjcpC